Please login to the form below

Not currently logged in
Email:
Password:

Chugai

This page shows the latest Chugai news and features for those working in and with pharma, biotech and healthcare.

First blood to Roche in Hemlibra patent fight with Shire

First blood to Roche in Hemlibra patent fight with Shire

A Tokyo court has found in favour of the Swiss group and recommended that Shire’s challenge against majority-owned Japanese affiliate Chugai should be dismissed. ... A ruling on the US patent battle could come later this year, according to Shire, which

Latest news

More from news
Approximately 5 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • Japanese pharma pulls no punches with post-Brexit UK Japanese pharma pulls no punches with post-Brexit UK

    The level of investment on the pharmaceutical side is considerable. The Japanese Pharmaceutical Group (JPG), an association of nine drugmakers - Astellas, Chugai, Daiichi-Sankyo, Eisai, Kowa, Mitsubishi Tanabe, Otsuka, Shionogi and

  • Deal Watch May 2016 Deal Watch May 2016

    In the ever popular oncology field, Chugai has signed up with Osaka University for a multiyear investment worth $91.1m to focus on the development of treatments for cancer and the

  • Medius Deal Watch table for March 2015 Medius Deal Watch table for March 2015

    225. Athersys / Chugai. Licence and collaboration Japan. Phase 2 stem cell therapy for treatment of ischaemic stroke.

  • Pharma deals during August 2014 Pharma deals during August 2014

    Rumours of a $10bn Chugai bid have swirled for weeks but to no avail. ... This is Roche's largest acquisition since 2009 when the remaining stake in Genentech was acquired and may well have put paid to plans to fully acquire Chugai.

  • Interview: Christopher Boulton, AstraZeneca Interview: Christopher Boulton, AstraZeneca

    Forxiga is set to face competition from other SGLT2 inhibitors either recently approved or on the horizon, including Janssen/Mitsubishi Tanabe's Invokana (canagliflozin), Sanofi/Chugai's tofogliflozin and

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Atlantis Healthcare

    Internal Chugai Award. Global Best Practice Sharing Awards – Silver medallist, 2014 .

  • Atlantis Healthcare

    Internal Chugai Award. Global Best Practice Sharing Awards – Silver medallist, 2014 .

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics